DC-SIGN activation inhibits miR-185 transcription and enhances VEGF and MMP-9 transcription toward the pathway of PI3K/Akt/b-catenin, promoting CRC metastasis [105]. The gene discussed is CD209; the disease is colorectal carcinoma.